Home » Newsletters » BioWorld

BioWorld

Oct. 2, 1997

View Archived Issues

Cytokine With Costimulator Doubled Tumor Regression; Human Trial Next Spring

Amylin Opts For $30M Loan From J&J For Pramlintide Trials

Matrix Restructures To Focus On Cancer; Lays Off 66 Staffers

Serono's Multiple Sclerosis Drug Strong In Phase III Studies

BioWorld Stock Report For Public Biotechnology Companies Part 2

Aradigm Signs Potential $40M Inhaler Deal With SmithKline

BioWorld Stock Report For Public Biotechnology Companies Part 1

Other News To Note

Cor Therapeutics Amends FDA Submission For Integrilin